Author:
Rutkowski Stefan,Kortmann Rolf-Dieter
Publisher
Springer Berlin Heidelberg
Reference26 articles.
1. Bailey CC, Gnekow A, Wellek S et al (1995) Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International Society of Pediatric Oncology (SIOP) and the German Society of Pediatric Oncology (GPO): SIOP II. Med Ped Oncol 25:166–178
2. Bloom HJG, Thorton H, Schweisguth O (1982) SIOP medulloblastoma and high grade ependymoma therapeutic clinical trail: preliminary results (1975–1981). In: Raybauld C, Clement R, Lebreuli G, Bernard JL (Hrsg) Pediatric oncology. Excerpta Medica, Amsterdam Oxford Pincerton, S 309–322
3. Bueren AO von, Kortmann RD, von Hoff K et al (2016) Treatment of children and adolescents with metastatic medulloblastoma and prognostic relevance of clinical and biological parameters. J Clin Oncol., in press 34:4151–4160
4. Calaminus G, Kortmann R, Worch J et al (2013) SIOP CNS GCT 96: final report of outcome of a prospective, multinational nonrandomized trial for children and adults with intracranial germinoma, comparing craniospinal irradiation alone with chemotherapy followed by focal primary site irradiation for patients with localized disease. Neuro Oncol 15(6):788–796
5. Caputy AJ, Mc Cullough DC, Manz HJ et al (1987) A review of the factors influencing the prognosis of medulloblastoma. The importance of cell differentiation. J Neurosurg 66:80–87